Verona Pharma to Present at Jefferies London Healthcare Conference
Verona Pharma (Nasdaq: VRNA) announces its participation in the upcoming Jefferies London Healthcare Conference. The company's senior management will deliver a company overview on Tuesday, November 19, 2024, at 6:30 a.m. ET / 11:30 a.m. GMT.
A webcast of the presentation will be accessible through the Events and Presentations section on the Investors page of Verona Pharma's website. The company has provided contact information for investor relations, US investor enquiries, and international/US media enquiries for those seeking additional information.
Verona Pharma (Nasdaq: VRNA) annuncia la sua partecipazione alla prossima Jefferies London Healthcare Conference. La direzione senior dell'azienda presenterà una panoramica aziendale martedì 19 novembre 2024, alle 6:30 a.m. ET / 11:30 a.m. GMT.
Un webcast della presentazione sarà disponibile nella sezione Eventi e Presentazioni nella pagina Investitori del sito web di Verona Pharma. L'azienda ha fornito informazioni di contatto per le relazioni con gli investitori, le richieste da parte degli investitori statunitensi e per i media internazionali/statunitensi per coloro che cercano ulteriori informazioni.
Verona Pharma (Nasdaq: VRNA) anuncia su participación en la próxima Jefferies London Healthcare Conference. La alta dirección de la empresa ofrecerá una visión general de la compañía el martes 19 de noviembre de 2024, a las 6:30 a.m. ET / 11:30 a.m. GMT.
Una transmisión en vivo de la presentación estará disponible en la sección de Eventos y Presentaciones en la página de Inversores del sitio web de Verona Pharma. La compañía ha proporcionado información de contacto para relaciones con inversionistas, consultas de inversionistas en EE. UU. y consultas de medios internacionales/estadounidenses para quienes busquen información adicional.
베로나 파마 (Nasdaq: VRNA)는 다가오는 제퍼리즈 런던 헬스케어 컨퍼런스에 참여한다고 발표했습니다. 회사의 고위 경영진은 2024년 11월 19일 화요일 오전 6시 30분 ET / 오전 11시 30분 GMT에 회사 개요를 전달할 예정입니다.
발표의 웹캐스트는 베로나 파마 웹사이트의 투자자 페이지의 이벤트 및 발표 섹션에서 접근할 수 있습니다. 회사는 추가 정보를 원하는 경우 투자자 관계, 미국 투자자 문의 및 국제/미국 언론 문의를 위한 연락처 정보를 제공하였습니다.
Verona Pharma (Nasdaq: VRNA) annonce sa participation à la prochaine Jefferies London Healthcare Conference. La direction senior de l'entreprise présentera un aperçu de la société le mardi 19 novembre 2024, à 6h30 ET / 11h30 GMT.
Un webinaire de la présentation sera accessible dans la section Événements et Présentations sur la page des Investisseurs du site web de Verona Pharma. L'entreprise a fourni des informations de contact pour les relations avec les investisseurs, les demandes d'investisseurs américains et les demandes de médias internationaux/ américains pour ceux qui recherchent des informations supplémentaires.
Verona Pharma (Nasdaq: VRNA) kündigt seine Teilnahme an der bevorstehenden Jefferies London Healthcare Conference an. Das obere Management des Unternehmens wird am Dienstag, den 19. November 2024, um 6:30 Uhr ET / 11:30 Uhr GMT einen Unternehmensüberblick geben.
Ein Webcast der Präsentation wird im Bereich Veranstaltungen und Präsentationen auf der Investorenseite von Verona Pharma verfügbar sein. Das Unternehmen hat Kontaktinformationen für die Investor Relations, Anfragen von US-Investoren und internationale/US-Medienanfragen bereitgestellt, für diejenigen, die zusätzliche Informationen suchen.
- None.
- None.
LONDON and RALEIGH, N.C., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”) announces that senior management will present a company overview at the Jefferies London Healthcare Conference on Tuesday, November 19, 2024, at 6:30 a.m. ET / 11:30 a.m. GMT.
A webcast of the event will be available on the Events and Presentations link on the Investors page of the Company’s website, www.veronapharma.com.
For further information please contact:
| Verona Pharma plc | Tel: +1-844-341-9901 |
| Victoria Stewart, Senior Director of Investor Relations and Communications | IR@veronapharma.com |
| Argot Partners (US Investor Enquiries) | Tel: +1-212-600-1902 verona@argotpartners.com |
| Ten Bridge Communications International / US Media Enquiries | Tel: +1-781-316-4424 tbcverona@tenbridgecommunications.com |
| Wendy Ryan | |
About Verona Pharma
Verona Pharma is a biopharmaceutical company focused on developing and commercializing innovative therapies for the treatment of chronic respiratory diseases with significant unmet medical needs. OhtuvayreTM (ensifentrine) is the Company’s first commercial product and the first inhaled therapy for the maintenance treatment of COPD that combines bronchodilator and non-steroidal anti-inflammatory activities in one molecule. Ensifentrine has potential applications in non-cystic fibrosis bronchiectasis, cystic fibrosis, asthma and other respiratory diseases. For more information, please visit www.veronapharma.com.
FAQ
When is Verona Pharma (VRNA) presenting at the Jefferies London Healthcare Conference?
How can investors watch Verona Pharma's (VRNA) Jefferies conference presentation?
What will be presented at Verona Pharma's (VRNA) Jefferies conference appearance?
